These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 15942450)

  • 1. Pharmacogenomics of blood pressure response to antihypertensive treatment.
    Mellen PB; Herrington DM
    J Hypertens; 2005 Jul; 23(7):1311-25. PubMed ID: 15942450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics of antihypertensive treatment.
    Arnett DK; Claas SA; Glasser SP
    Vascul Pharmacol; 2006 Feb; 44(2):107-18. PubMed ID: 16356784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics of antihypertensive drug responses.
    Schwartz GL; Turner ST
    Am J Pharmacogenomics; 2004; 4(3):151-60. PubMed ID: 15174896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-gene interactions between genetic polymorphisms and antihypertensive therapy.
    Schelleman H; Stricker BH; De Boer A; Kroon AA; Verschuren MW; Van Duijn CM; Psaty BM; Klungel OH
    Drugs; 2004; 64(16):1801-16. PubMed ID: 15301563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics in hypertension: present practicalities and future potential.
    Brain N; Dominiczak AF
    J Hypertens; 2005 Jul; 23(7):1327-9. PubMed ID: 15942451
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacogenomics of Hypertension Treatment.
    Rysz J; Franczyk B; Rysz-Górzyńska M; Gluba-Brzózka A
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies.
    Schmieder RE; Martus P; Klingbeil A
    JAMA; 1996 May; 275(19):1507-13. PubMed ID: 8622227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.
    Psaty BM; Lumley T; Furberg CD; Schellenbaum G; Pahor M; Alderman MH; Weiss NS
    JAMA; 2003 May; 289(19):2534-44. PubMed ID: 12759325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension.
    Levi-Marpillat N; Macquin-Mavier I; Tropeano AI; Parati G; Maison P
    Hypertens Res; 2014 Jun; 37(6):585-90. PubMed ID: 24671016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of genes implicated in cardiovascular disease on blood pressure response to treatment among treatment-naive hypertensive African Americans in the GenHAT study.
    Do AN; Lynch AI; Claas SA; Boerwinkle E; Davis BR; Ford CE; Eckfeldt JH; Tiwari HK; Arnett DK; Irvin MR
    J Hum Hypertens; 2016 Sep; 30(9):549-54. PubMed ID: 26791477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of the optic disc structure with the use of antihypertensive medications: the thessaloniki eye study.
    Harris A; Topouzis F; Wilson MR; Founti P; Kheradiya NS; Anastasopoulos E; Gong G; Yu F; Jonescu-Cuypers CP; Pappas T; Koskosas A; Coleman AL
    J Glaucoma; 2013 Sep; 22(7):526-31. PubMed ID: 22411020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Individual sensitivity to antihypertensive drugs: genetic aspects].
    Minushkina LO; Zateĭshchikov DA; Sidorenko BA
    Kardiologiia; 2005; 45(7):58-65. PubMed ID: 16091664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update on the pharmacogenetics of treating hypertension.
    Fontana V; Luizon MR; Sandrim VC
    J Hum Hypertens; 2015 May; 29(5):283-91. PubMed ID: 25355012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in antihypertensive treatment--lessons from the National Acute Stroke Israeli (NASIS) registry.
    Koifman E; Tanne D; Molshatzki N; Leibowitz A; Grossman E
    Blood Press; 2014 Oct; 23(5):262-9. PubMed ID: 24483945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Goals of antihypertensive therapy.
    McVeigh GE; Flack J; Grimm R
    Drugs; 1995 Feb; 49(2):161-75. PubMed ID: 7729325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care.
    Vijan S; Hayward RA
    Ann Intern Med; 2003 Apr; 138(7):593-602. PubMed ID: 12667032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which drug for treatment of hypertension?
    Cutler J
    Lancet; 1999 Feb; 353(9153):604-5. PubMed ID: 10030320
    [No Abstract]   [Full Text] [Related]  

  • 20. Intraclass differences among antihypertensive drugs.
    Feldman RD; Hussain Y; Kuyper LM; McAlister FA; Padwal RS; Tobe SW
    Annu Rev Pharmacol Toxicol; 2015; 55():333-52. PubMed ID: 25251994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.